Category: diverse
-
Wall Street dives into Amgen’s diverse biopharma strategies By Investing.com
•
Amgen Inc (NASDAQ:AMGN). Update the financial material Amgen Inc. continues In being a prominent force in the biopharmaceutical sector, with a focus on developing innovative treatments for serious diseases. The company’s involvement in areas such as oncology, cardiovascular disease, bone health, neuroscience, nephrology, infections, rare diseases, and its strategic interest…